Physician profile
Omar Lazaro Esponda
NPI 1295938611
$1,183.01
in general payments reported to CMS, 2019-2025
9 companies · $251 in 2025
The $251 reported for 2025 was more than what a typical Phlebology provider received nationally (typical 2025 total: $141).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $133 · 2021: $262 · 2022: $170 · 2023: $58.24 · 2024: $34.87 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $344.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $411.41 | 2019-2022 | |
| Boston Scientific Corporation | $148.57 | 2022-2023 | Varithena Administration Pack |
| Lemaitre Vascular, INC. | $125.00 | 2021 | |
| Tactile Systems Technology INC | $114.86 | 2022-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Cashflow Solutions, LLC | $103.60 | 2023-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Lilly USA, LLC | $90.00 | 2019 | |
| Bard Peripheral Vascular, INC. | $77.36 | 2025 | Venovo, Venclose Maven Catheter |
| Pfizer Pharmaceuticals LLC | $63.88 | 2019 | |
| Medtronic, INC. | $48.33 | 2023-2025 | Venaseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Esponda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.